Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 50.011 |
|
|||||
| News | - | ||||||
| Tageshoch | 3,91 | Niedrig Hoch |
|||||
| Tagestief | 3,62 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Eagle Pharmaceuticals Inc | EGRX | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,02 | -0,54% | 3,71 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 3,73 | 3,62 | 3,91 | 3,71 | 3,73 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 841 | 50.011 | US$ 3,70 | US$ 184.935 | - | 3,2101 - 23,52 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 22:04:36 | 27 | US$ 3,71 | USD |
Finanzwerte EGRX
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 47,92M | 12,99M | - | 316,61M | 35,64M | 2,74 | 1,34 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Eagle Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 29.5.2024 | 14:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22.5.2024 | 15:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.5.2024 | 15:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10.5.2024 | 23:27 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 08.3.2024 | 22:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01.3.2024 | 22:40 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 01.3.2024 | 13:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01.3.2024 | 02:23 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 29.2.2024 | 22:44 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 29.2.2024 | 14:09 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.2.2024 | 23:09 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
| 13.2.2024 | 21:53 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
Forum Eagle Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
EGRX Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 3,45 | 4,13 | 3,26 | 3,73 | 100.420 | 0,26 | 7,54% |
| 1 Monat | 4,70 | 4,98 | 3,2101 | 3,93 | 163.370 | -0,99 | -21,06% |
| 3 Monate | 5,96 | 6,19 | 3,2101 | 4,53 | 151.068 | -2,25 | -37,75% |
| 6 Monate | 5,89 | 6,81 | 3,2101 | 4,99 | 206.060 | -2,18 | -37,01% |
| 1 Jahr | 18,42 | 23,52 | 3,2101 | 9,75 | 190.599 | -14,71 | -79,86% |
| 3 Jahre | 37,76 | 58,25 | 3,2101 | 26,93 | 154.752 | -34,05 | -90,17% |
| 5 Jahre | 51,43 | 64,94 | 3,2101 | 35,53 | 150.531 | -47,72 | -92,79% |
